WOMEN WHO INITIATE THERAPY OF HIV INFECTION DURING PREGNANCY PACTG 1022

怀孕期间开始治疗 HIV 感染的女性 PACTG 1022

• 批准号: 7375343
• 负责人: Daniel J. Garry
• 金额: $ 2.02万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375343
• 关键词: WOMEN; WHO; INITIATE; THERAPY; HIV

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. PACTG 1022 The purpose of this study is to see if one of two different combinations of drugs are better at treating HIV in pregnant women and how long these drugs will stay effective. It will also measure levels of drugs in the blood before and after pregnancy and see if there are any special problems with taking HIV drugs during pregnancy.

该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金，因此可以在其他 CRISP 条目中得到体现。列出的机构是中心的机构，不一定是研究者的机构。 PACTG 1022 本研究的目的是了解两种不同药物组合中的一种是否能更好地治疗孕妇的艾滋病毒，以及这些药物的有效性能持续多久。它还将测量怀孕前后血液中的药物水平，看看怀孕期间服用艾滋病毒药物是否存在任何特殊问题。